Chemical inhibitors of 1700016L21Rik can exert their inhibitory effects through various mechanisms by targeting different signaling pathways and enzymes that are crucial for the protein's function. Staurosporine, a potent protein kinase inhibitor, can lead to the functional inhibition of 1700016L21Rik by obstructing the kinase-dependent signaling pathways upon which the protein may rely for its activity. Similarly, Bisindolylmaleimide I serves as a selective inhibitor of protein kinase C (PKC), which is likely involved in the downstream signaling required for 1700016L21Rik function. Inhibition of PKC can thus disrupt crucial signaling cascades and impede the functional capabilities of 1700016L21Rik.
Further down the line of kinase inhibition, LY294002 and Wortmannin act as phosphoinositide 3-kinases (PI3K) inhibitors, which can disrupt the PI3K/AKT pathway, potentially a significant contributor to the activity of 1700016L21Rik. Rapamycin, by inhibiting mTOR, can also influence the protein's function, as mTOR is a central regulator of cell growth and survival. U0126 and PD98059 target the MEK/ERK pathway, with U0126 being a selective MEK1/2 inhibitor and PD98059 a MEK inhibitor, both leading to reduced ERK pathway signaling, which can inhibit the processes 1700016L21Rik is involved in. SB203580, targeting p38 MAP kinase, and SP600125, inhibiting JNK, are agents that can disrupt the MAPK signaling pathway, a crucial mediator of cellular responses to stress and inflammatory cytokines, which can be integral to the function of 1700016L21Rik. Dasatinib and PP2, as Src family tyrosine kinase inhibitors, can block critical phosphorylation events and signaling networks necessary for 1700016L21Rik activity. Finally, ZM-447439, an Aurora kinase inhibitor, can disrupt cell cycle-related signaling pathways, potentially involving the functional scope of 1700016L21Rik, leading to its inhibition. Through these distinct yet interconnected pathways, the selected chemicals can collectively inhibit the functional activity of 1700016L21Rik by disrupting the signaling events and enzyme activities it requires.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $150.00 $388.00 | 113 | |
Inhibits various protein kinases that could be crucial for 1700016L21Rik signaling or activity, leading to functional inhibition. | ||||||
Bisindolylmaleimide I (GF 109203X) | 133052-90-1 | sc-24003A sc-24003 | 1 mg 5 mg | $103.00 $237.00 | 36 | |
Specifically inhibits PKC, which may be necessary for 1700016L21Rik's activity by disrupting downstream signaling pathways. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
PI3K inhibitor that would disrupt the PI3K/AKT signaling pathway, potentially essential for the activity of 1700016L21Rik. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $66.00 $219.00 $417.00 | 97 | |
Acts as a PI3K inhibitor, leading to a reduction in AKT pathway activity that 1700016L21Rik may rely on for its function. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
Forms a complex with FKBP12 to inhibit mTOR, a pathway that 1700016L21Rik could depend on for its functional activity. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $63.00 $241.00 | 136 | |
Selective MEK1/2 inhibitor that would prevent activation of ERK1/2, potentially inhibiting pathways that 1700016L21Rik utilizes. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $39.00 $90.00 | 212 | |
Inhibits MEK, which indirectly could lead to a decrease in ERK pathway signaling, affecting the functional activity of 1700016L21Rik. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $88.00 $342.00 | 284 | |
P38 MAP kinase inhibitor which could obstruct the MAPK signaling pathway, likely involved in 1700016L21Rik function. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
Inhibits JNK, potentially disrupting a signaling pathway that 1700016L21Rik may use for its activity. | ||||||
Dasatinib | 302962-49-8 | sc-358114 sc-358114A | 25 mg 1 g | $47.00 $145.00 | 51 | |
Src family tyrosine kinase inhibitor which may block signaling pathways required for 1700016L21Rik activity. | ||||||